Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer
Clinical trial NCT02476539 · COMPLETED
Trial details
- NCT number
- NCT02476539
- Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-14
- Primary completion
- 2023-09-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.